BE855766A - Composition antibacterienne - Google Patents

Composition antibacterienne

Info

Publication number
BE855766A
BE855766A BE178510A BE178510A BE855766A BE 855766 A BE855766 A BE 855766A BE 178510 A BE178510 A BE 178510A BE 178510 A BE178510 A BE 178510A BE 855766 A BE855766 A BE 855766A
Authority
BE
Belgium
Prior art keywords
antibacterial composition
antibacterial
composition
Prior art date
Application number
BE178510A
Other languages
English (en)
French (fr)
Inventor
H Aoki
T Nishiura
H Imanaka
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of BE855766A publication Critical patent/BE855766A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BE178510A 1976-06-18 1977-06-16 Composition antibacterienne BE855766A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51072458A JPS6049602B2 (ja) 1976-06-18 1976-06-18 抗菌剤

Publications (1)

Publication Number Publication Date
BE855766A true BE855766A (fr) 1977-12-16

Family

ID=13489871

Family Applications (1)

Application Number Title Priority Date Filing Date
BE178510A BE855766A (fr) 1976-06-18 1977-06-16 Composition antibacterienne

Country Status (8)

Country Link
US (1) US4092411A (xx)
JP (1) JPS6049602B2 (xx)
AU (1) AU512893B2 (xx)
BE (1) BE855766A (xx)
DE (1) DE2727247A1 (xx)
FR (1) FR2354768A1 (xx)
GB (1) GB1524180A (xx)
NL (1) NL7706461A (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196193A (en) * 1978-02-15 1980-04-01 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009931A1 (en) * 2003-03-20 2005-01-13 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923977A (en) * 1972-08-29 1975-12-02 Fujisawa Pharmaceutical Co Antibiotic FR-1923 substance

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196193A (en) * 1978-02-15 1980-04-01 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition

Also Published As

Publication number Publication date
AU2620677A (en) 1978-12-21
NL7706461A (nl) 1977-12-20
DE2727247A1 (de) 1977-12-29
AU512893B2 (en) 1980-11-06
JPS6049602B2 (ja) 1985-11-02
US4092411A (en) 1978-05-30
FR2354768A1 (fr) 1978-01-13
FR2354768B1 (xx) 1981-01-09
GB1524180A (en) 1978-09-06
JPS52156931A (en) 1977-12-27

Similar Documents

Publication Publication Date Title
BE853974A (fr) Agents antibacteriens
SE7713361L (sv) Komposition
AT355871B (de) Insektizide zusammensetzung
IT1075517B (it) Composizioni antitraspiranti anidre
BR7703411A (pt) Composicoes polimericas auto-extinguiveis
BE852727A (nl) Polypropyeencomposities
BR7703469A (pt) Composicao curavel
SE7704946L (sv) Stannopyrofosfat-teknetium-99mm-kompositioner
FI781201A (fi) Antibakteriella aemnen
BR7701889A (pt) Composicao aperfeicoada de plimistura
BR7700772A (pt) Composicao curavel
TR20136A (tr) Ensektisid terkipler
BE862082A (fr) Composition orale antibacterienne
SE7701722L (sv) Antibakteriella foreningar
BR7702372A (pt) Composicao curavel
BE858475A (fr) Compositions photoreticulables
DK384077A (da) Komposition
MX3553E (es) Composicion polumerica mejorada
FR2315926A1 (fr) Agents antibacteriens
SE7612936L (sv) Hygienisk-kosmetiska kompositioner
SE7714312L (sv) Antibiotiska kompositioner
FI781217A (fi) Antibakteriella aemnen
RO71904A (ro) Compozitie erbicida sinergetica
FI780933A (fi) Antimikrobial komposition
SE7808114L (sv) Antibakteriella kompositioner

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO. LTD

Effective date: 19840616